Encompass Health (EHC)
(Delayed Data from NYSE)
$84.77 USD
+0.80 (0.95%)
Updated Jul 10, 2024 04:00 PM ET
After-Market: $84.75 -0.02 (-0.02%) 7:20 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
EHC 84.77 +0.80(0.95%)
Will EHC be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for EHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EHC
Encompass Health (EHC), Piedmont Expand Ties to Serve Georgia
Here's Why Encompass Health (EHC) is a Strong Growth Stock
EHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Encompass Health (EHC) is a Strong Growth Stock
Reasons to Retain Baxter International (BAX) in Your Portfolio Now
Humana (HUM) Ties Up With PsychArmor for Better Veteran Care
Other News for EHC
Encompass Health and Piedmont announce joint venture to own and operate rehabilitation hospital in Augusta, Georgia
TimesSquare Capital Global Health Care Q1 2024 Commentary
Baptist Health Rehabilitation Hospital, a 40-bed inpatient rehabilitation hospital, now open in Kentucky
How Is The Market Feeling About Encompass Health?
Encompass Health’s Strategic Debt Management and Liquidity Tactics